Trial Outcomes & Findings for Cranial Cup Use for the Prevention of Positional Head Shape Deformity in the NICU (NCT NCT01218087)
NCT ID: NCT01218087
Last Updated: 2017-02-03
Results Overview
Cranial abnormality measurements were obtained at hospital discharge by orthotists blinded to the study group assignment. Cranial abnormalities include both cranial index measures and cranial symmetry measures. Cranial index (normal measurement between 73%-85%) was obtained dividing the head width (M-L) by length (A-P) then multiplying it by 100%. Cranial symmetry (normal measurement of\<8mm) was obtained by calculating the difference in the right and left anterior-posterior measures.
TERMINATED
NA
88 participants
up to 120 days
2017-02-03
Participant Flow
Approximately 800 infants from the 4 participating NICUs were screened; most were excluded for an anticipated length of stay of \< 14 days, for medical reasons, and a few parents declined. The total number enrolled out of the approximately 800 screened was 88.
Participant milestones
| Measure |
Cranial Cup Device
The cranial cup device was used 12/24 hours and the moldable positioner device was used for positioning infants the remainder of the 24 hours.
|
Moldable Positioner Device
Moldable positioner device was used 24/24 hours as a comparison to the cranial cup and moldable positioner study arm.
|
|---|---|---|
|
Overall Study
STARTED
|
42
|
41
|
|
Overall Study
COMPLETED
|
27
|
35
|
|
Overall Study
NOT COMPLETED
|
15
|
6
|
Reasons for withdrawal
| Measure |
Cranial Cup Device
The cranial cup device was used 12/24 hours and the moldable positioner device was used for positioning infants the remainder of the 24 hours.
|
Moldable Positioner Device
Moldable positioner device was used 24/24 hours as a comparison to the cranial cup and moldable positioner study arm.
|
|---|---|---|
|
Overall Study
Death
|
2
|
1
|
|
Overall Study
Withdrawal by Subject
|
5
|
0
|
|
Overall Study
Transferred
|
8
|
5
|
Baseline Characteristics
Cranial Cup Use for the Prevention of Positional Head Shape Deformity in the NICU
Baseline characteristics by cohort
| Measure |
Cranial Cup Device
n=27 Participants
cranial cup device: The cranial cup device was used 12/24 hours (alternating with the moldable positioner device) and was evaluated for feasibility, safety and efficacy for preventing head shape deformity in the infant
|
Moldable Positioner Device
n=35 Participants
moldable positioner device: This positioning device was used 24/24 hours as a comparison to the cranial cup device.
|
Total
n=62 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
0 days
n=5 Participants
|
0 days
n=7 Participants
|
0 days
n=5 Participants
|
|
Gender
Female
|
9 Participants
n=5 Participants
|
13 Participants
n=7 Participants
|
22 Participants
n=5 Participants
|
|
Gender
Male
|
18 Participants
n=5 Participants
|
22 Participants
n=7 Participants
|
40 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
White
|
15 participants
n=5 Participants
|
26 participants
n=7 Participants
|
41 participants
n=5 Participants
|
|
Race/Ethnicity, Customized
African American
|
7 participants
n=5 Participants
|
7 participants
n=7 Participants
|
14 participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Asian
|
1 participants
n=5 Participants
|
0 participants
n=7 Participants
|
1 participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Native Hawaiian
|
0 participants
n=5 Participants
|
1 participants
n=7 Participants
|
1 participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Hispanic
|
4 participants
n=5 Participants
|
1 participants
n=7 Participants
|
5 participants
n=5 Participants
|
|
Region of Enrollment
United States
|
27 participants
n=5 Participants
|
35 participants
n=7 Participants
|
62 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: up to 120 daysCranial abnormality measurements were obtained at hospital discharge by orthotists blinded to the study group assignment. Cranial abnormalities include both cranial index measures and cranial symmetry measures. Cranial index (normal measurement between 73%-85%) was obtained dividing the head width (M-L) by length (A-P) then multiplying it by 100%. Cranial symmetry (normal measurement of\<8mm) was obtained by calculating the difference in the right and left anterior-posterior measures.
Outcome measures
| Measure |
Cranial Cup Device
n=27 Participants
cranial cup device: The cranial cup device was used 12/24 hours (alternating with the moldable positioner device) and was evaluated for feasibility, safety and efficacy for preventing head shape deformity in the infant. Although infants in this arm did use the moldable positioner, they were analyzed separately from the comparison group.
|
Moldable Positioner Device
n=35 Participants
moldable positioner device: This positioning device was used 24/24 hours as a comparison to the cranial cup device.
|
|---|---|---|
|
Cranial Abnormalities Were Measured at Hospital Discharge
|
46 % participant cranial abnormalities
|
19 % participant cranial abnormalities
|
SECONDARY outcome
Timeframe: daily up to 120 daysdaily log of cardiorespiratory events (apnea, bradycardia, oxygen desaturation) collected on a daily positioning log at the infant's bedside
Outcome measures
| Measure |
Cranial Cup Device
n=27 Participants
cranial cup device: The cranial cup device was used 12/24 hours (alternating with the moldable positioner device) and was evaluated for feasibility, safety and efficacy for preventing head shape deformity in the infant. Although infants in this arm did use the moldable positioner, they were analyzed separately from the comparison group.
|
Moldable Positioner Device
n=35 Participants
moldable positioner device: This positioning device was used 24/24 hours as a comparison to the cranial cup device.
|
|---|---|---|
|
Incidence of Cardiorespiratory
|
5.4 cardioresp. events/100hrs of device use
|
5.9 cardioresp. events/100hrs of device use
|
Adverse Events
Cranial Cup Device
Moldable Positioner Device
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place